Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Akero Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- +23 vs. Q3 2024
- Shares held
- 74.2M
- +1.18M (+1.6%) vs. Q3 2024
- Total value
- $2.06B
- −$30.5M (−1.5%) vs. Q3 2024
- New holders
- 41
- 65 more added
- Sold out
- 18
- 50 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −10,159−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −10,087−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −7,571−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,012−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |